Your browser doesn't support javascript.
loading
A novel semi-mechanistic tumor growth fraction model for translation of preclinical efficacy of anti-glypican 3 antibody drug conjugate to human.
Singh, Renu; Kozhich, Alexander; Pan, Chin; Lee, Francis; Cardarelli, Pina; Vangipuram, Rangan; Iyer, Rama; Marathe, Punit.
Afiliação
  • Singh R; Metabolism and Pharmacokinetics, Bristol-Myers Squibb, Lawrenceville, New Jersey, USA.
  • Kozhich A; Bioanalytical Sciences, Bristol-Myers Squibb, Lawrenceville, New Jersey, USA.
  • Pan C; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, California, USA.
  • Lee F; Oncology Biology, Bristol-Myers Squibb, Lawrenceville, New Jersey, USA.
  • Cardarelli P; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, California, USA.
  • Vangipuram R; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, California, USA.
  • Iyer R; Metabolism and Pharmacokinetics, Bristol-Myers Squibb, Lawrenceville, New Jersey, USA.
  • Marathe P; Metabolism and Pharmacokinetics, Bristol-Myers Squibb, Lawrenceville, New Jersey, USA.
Biopharm Drug Dispos ; 41(8-9): 319-333, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32678919
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article